In last trading session, CERo Therapeutics Holdings Inc (NASDAQ:CERO) saw 0.38 million shares changing hands with its beta currently measuring 0.52. Company’s recent per share price level of $0.58 trading at $0.0 or 0.22% at ring of the bell on the day assigns it a market valuation of $3.27M. That closing price of CERO’s stock is at a discount of -20072.41% from its 52-week high price of $117.00 and is indicating a premium of 8.62% from its 52-week low price of $0.53. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.61 million shares which gives us an average trading volume of 1.82 million if we extend that period to 3-months.

CERo Therapeutics Holdings Inc (NASDAQ:CERO) trade information

Upright in the green during last session for gaining 0.22%, in the last five days CERO remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $0.58 price level, adding 12.13% to its value on the day. CERo Therapeutics Holdings Inc’s shares saw a change of -90.25% in year-to-date performance and have moved -10.00% in past 5-day. CERo Therapeutics Holdings Inc (NASDAQ:CERO) showed a performance of -2.01% in past 30-days. Number of shares sold short was 1.02 million shares which calculate 0.25 days to cover the short interests.

In 2025, company’s earnings growth rate is likely to be around 59.83% while estimates for its earnings growth in next 5 years are of 62.86%.

CERo Therapeutics Holdings Inc (NASDAQ:CERO)’s Major holders

Insiders are in possession of 13.89% of company’s total shares while institution are holding 11.77 percent of that, with stock having share float percentage of 13.67%. Investors also watch the number of corporate investors in a company very closely, which is 11.77% institutions for CERo Therapeutics Holdings Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 13.69 shares of worth $8010.0 or 0.25% of the total outstanding shares. The later fund manager was in possession of 1.12 shares on Mar 31, 2025 , making its stake of worth around $654.0 in the company or a holder of 0.02% of company’s stock.